Ra Medical Systems Retains KCSA Strategic Communications as Corporate Communications Counsel

Company Committed to Communicating with the Market about Corporate, Product Developments

News provided by

Jun 16, 2017, 10:40 ET

CARLSBAD, Calif. and NEW YORK, June 16, 2017 /PRNewswire/ -- Ra Medical Systems, makers of excimer lasers and catheters for cardiovascular and dermatological diseases, announced today that the Company has retained KCSA Strategic Communications (KCSA), a leading New York-based communications firm, to create a comprehensive, strategic communications campaign to increase awareness of Ra Medical Systems and help to communicate its broader vision to the marketplace and investment community. Ra Medical Systems recently announced the FDA market clearance and commercialization of its revolutionary DABRA™ System for the treatment of Peripheral Artery Disease.

With extensive experience in helping to build brands in the healthcare sector, including medical devices, healthcare services and biotechnology, KCSA will work with Ra Medical Systems' management team to develop programs that will enable the Company to differentiate itself from the competition, showcase its leadership position, focus on innovation and launch new products. Lewis Goldberg, Managing Partner at KCSA, will lead the communications team and provide strategic counsel on shareholder communications and broader communication issues.

"With the recent FDA market clearance and commercialization of DABRA, having a communications program in place to tell the Ra Medical Systems story to the medical and investment community is of the utmost importance," said Dean Irwrin, CEO, Ra Medical Systems. "The implementation of a comprehensive and strategic communications program will highlight our core strengths and demonstrate what differentiates us from the other players in the market. Most importantly, strong communications will enable our corporate vision to shine, ultimately maximizing shareholder value. Working with KCSA, one of the few integrated PR and IR firms in the country with vast healthcare industry experience, is a perfect fit for Ra Medical Systems as a result."

"In helping to build Ra Medical Systems' future, we know how vital it is that we craft and deliver the right messages that are unique to each stakeholder," added Goldberg. "Based on our experience in working with dozens of healthcare companies over the years, we believe that KCSA is the right firm to help tell Ra Medical Systems' story, and we look forward to capitalizing on our deep media relationships in this sector as the Company brings DABRA to even more doctors and patients around the country. This is all about providing patients with the most advanced, innovative technology that is better, safer, faster and less-expensive, compared to current treatments for Peripheral Artery Disease, the leading cause of limb amputations."

About Ra Medical Systems
Ra Medical Systems was founded in 2002 to commercialize excimer lasers and catheters for the treatment of dermatologic and cardiovascular diseases. Its flagship product, Pharos, launched in 2004 and revolutionized the dermatology world with its technology and affordable business model for greater patient access to treatment. Today, Ra Medical Systems continues to make history as it commercializes the DABRA System.

About KCSA Strategic Communications
KCSA is a fully integrated communications agency specializing in public relations, investor relations and social media, with expertise in financial and professional services, technology, healthcare, digital media and energy. Since 1969, the firm has demonstrated strategic thinking and program execution that drives results for its clients in the ever-changing communications and digital landscape. The firm's clients are its best references. For more information, please visit www.kcsa.com.

SOURCE KCSA Strategic Communications